103 related articles for article (PubMed ID: 9430940)
1. [Malignant neuroleptic syndrome, medical-psychiatric approach].
Giacamán P; Andresen M; Gareca N; Bitrán J; Dougnac A
Rev Med Chil; 1997 Feb; 125(2):195-9. PubMed ID: 9430940
[TBL] [Abstract][Full Text] [Related]
2. Neuroleptic malignant syndrome.
Haisma HJ; Constantinou E; Chinyanga HM
Cent Afr J Med; 1990 May; 36(5):141-3. PubMed ID: 2261628
[TBL] [Abstract][Full Text] [Related]
3. [Neuroleptic malignant syndrome. A case report].
Guadagnucci A; Tornaboni D; Vignali G; Mariotti M; Cincinelli A; Vignale L
Minerva Med; 1995; 86(7-8):327-30. PubMed ID: 7478078
[TBL] [Abstract][Full Text] [Related]
4. Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report.
Khan A; Jaffe JH; Nelson WH; Morrison B
J Clin Psychiatry; 1985 Jun; 46(6):244-6. PubMed ID: 3922961
[TBL] [Abstract][Full Text] [Related]
5. [A cocaine-induced variant of the neuroleptic malignant syndrome. A case study].
Smidt MH; Collumbien EC
Tijdschr Psychiatr; 2006; 48(5):399-404. PubMed ID: 16956032
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic malignant syndrome with delayed onset of fever following risperidone administration.
Norris B; Angeles V; Eisenstein R; Seale JP
Ann Pharmacother; 2006 Dec; 40(12):2260-4. PubMed ID: 17119106
[TBL] [Abstract][Full Text] [Related]
7. Survival of severe neuroleptic malignant syndrome in a 78-year-old man treated with dantrolene.
Kimerer NB; Parker DM; Sholer CM; Trammell JR
J Okla State Med Assoc; 1990 Mar; 83(3):122-4. PubMed ID: 2319382
[TBL] [Abstract][Full Text] [Related]
8. Electroconvulsive therapy in drug resistant neuroleptic malignant syndrome.
Patel AL; Shaikh WA; Khobragade AK; Soni HG; Joshi AS; Sahastrabuddhe GS
J Assoc Physicians India; 2008 Jan; 56():49-50. PubMed ID: 18472502
[TBL] [Abstract][Full Text] [Related]
9. [A successfully treated parkinsonian patient with neuroleptic malignant syndrome complicated by status epilepticus and disseminated intravascular coagulation].
Osoegawa M; Motomura S; Yamanaka H; Tamura K; Miyoshi T
Rinsho Shinkeigaku; 1999 Jun; 39(6):653-7. PubMed ID: 10502992
[TBL] [Abstract][Full Text] [Related]
10. [Acute catatonia and neuroleptic malignant syndrome. A case of infantile psychosis].
Revuelta E; Bordet R; Piquet T; Ghawche F; Destee A; Goudemand M
Encephale; 1994; 20(3):351-4. PubMed ID: 7916282
[TBL] [Abstract][Full Text] [Related]
11. Neuroleptic malignant syndrome treated with subcutaneous lisuride infusion.
Rodriguez ME; Luquin MR; Lera G; Delgado G; Salazar JM; Obeso JA
Mov Disord; 1990; 5(2):170-2. PubMed ID: 2325680
[TBL] [Abstract][Full Text] [Related]
12. [Neuroleptic malignant syndrome].
Chodorowski Z; Anand JS; Rutkowski P
Przegl Lek; 2003; 60(4):299-301. PubMed ID: 14569909
[TBL] [Abstract][Full Text] [Related]
13. A fulminant case of neuroleptic malignant syndrome.
Teo SK; Lam KN; Chew WL
Singapore Med J; 1994 Feb; 35(1):110-1. PubMed ID: 8009269
[TBL] [Abstract][Full Text] [Related]
14. [A case of neuroleptic malignant syndrome associated with reversible leukoencephalopathy].
Sugimoto T; Tsunoda S; Shindou K; Shiozawa Z
Rinsho Shinkeigaku; 1999 Nov; 39(11):1147-9. PubMed ID: 10689939
[TBL] [Abstract][Full Text] [Related]
15. Neuroleptic malignant syndrome and lithium carbonate.
Fava S; Galizia AC
J Psychiatry Neurosci; 1995 Jul; 20(4):305-6. PubMed ID: 7647084
[TBL] [Abstract][Full Text] [Related]
16. [A patient with Parkinson's disease complicated by hypothyroidism who developed malignant syndrome after discontinuation of etizolam].
Kawajiri M; Ohyagi Y; Furuya H; Araki T; Inoue N; Esaki S; Yamada T; Kira J
Rinsho Shinkeigaku; 2002 Feb; 42(2):136-9. PubMed ID: 12424963
[TBL] [Abstract][Full Text] [Related]
17. [Intensive care treatment for neuroleptic malignant syndrome].
Hensel M; Böhler K; Marnitz R; Binder C; von Brevern M
Anasthesiol Intensivmed Notfallmed Schmerzther; 2010 Jul; 45(7-8):448-55. PubMed ID: 20665353
[TBL] [Abstract][Full Text] [Related]
18. Zuclopenthixol-induced neuroleptic malignant syndrome in an adolescent girl.
Erermis S; Bildik T; Tamar M; Gockay A; Karasoy H; Ercan ES
Clin Toxicol (Phila); 2007; 45(3):277-80. PubMed ID: 17453880
[TBL] [Abstract][Full Text] [Related]
19. [Pharmaceutical Approach for the Diagnosis and Treatment of Malignant Syndrome: A Case Study].
Kameda K; Watarai K; Takahashi K; Shoko T; Koinuma M; Ikushima G
Yakugaku Zasshi; 2016; 136(6):925-9. PubMed ID: 27252070
[TBL] [Abstract][Full Text] [Related]
20. [Beneficial effect of bromocriptine in a patient with malignant syndrome and hepatic dysfunctions].
Onaka A; Aibiki M; Shirakawa Y; Chikano S; Yokono S; Ogli K
Masui; 1993 Mar; 42(3):431-4. PubMed ID: 8468790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
